FingerTango (FGRT.F) 주식 개요An investment holding company, develops and publishes online mobile games in the People’s Republic of China. 자세히 보기FGRT.F 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성6/6배당0/6위험 분석지난 5년간 매년 수익이 59.4% 감소했습니다.주식은 유동성이 매우 낮습니다의미 있는 시가총액이 없습니다($20M)모든 위험 점검 보기FGRT.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.01271.9% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-626m1b2016201920222025202620282031Revenue CN¥415.2mEarnings CN¥53.8mAdvancedSet Fair ValueView all narrativesFingerTango Inc. 경쟁사Motorsport GamesSymbol: NasdaqCM:MSGMMarket cap: US$23.7mGigaMediaSymbol: NasdaqCM:GIGMMarket cap: US$16.5mDarkirisSymbol: NasdaqCM:DKIMarket cap: US$7.9mGamehaus HoldingsSymbol: NasdaqCM:GMHSMarket cap: US$50.6m가격 이력 및 성과FingerTango 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가HK$0.01252주 최고가HK$0.01252주 최저가HK$0.012베타1.211개월 변동0%3개월 변동n/a1년 변동-77.55%3년 변동n/a5년 변동n/aIPO 이후 변동-76.32%최근 뉴스 및 업데이트공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.공시 • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026공시 • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.공시 • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025공시 • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.더 많은 업데이트 보기Recent updates공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.공시 • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026공시 • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.공시 • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025공시 • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.공시 • Dec 19+ 1 more updateFingertango Inc. Announces Resignation of Liu Jie as CEOThe board of directors of FingerTango Inc. announced that Mr. Liu Jie has tendered his resignation as chief executive officer of the Company, all with effect from 16 December 2024, due to his other business commitments.공시 • Dec 05FingeTtango Inc. Appoints Li Nini as an Executive DirectorThe board (the "Board") of directors (the "Directors" each a "Director") of FingerTango Inc. announce that, Ms. Li Nini ("Ms. Li") has been appointed as an executive Director of the Company with effect from 5 December 2024. The biographical details of Ms. Li are set out below: Ms. Li Nin, aged 42, join the Group on 3 December 2013. Ms. Li is vice president of the Group, mainly responsible for the business operation and project management. She has served as vice president of Shanghai Youmin Networks Technology Limited, a subsidiary of the Company, since December 2013. She is also the director of certain subsidiaries of the Group. Prior to joining the Group, she has worked with the founders of the Group. Ms. Li has over 10 years of experience in online game operation and management. Ms. Li graduated from Guangdong Ocean University with a bachelor degree in food science and engineering in June 2006 and graduated from Guangdong University of Technology with a master degree in food science in June 2009.공시 • Aug 16FingerTango Inc. to Report First Half, 2024 Results on Aug 28, 2024FingerTango Inc. announced that they will report first half, 2024 results on Aug 28, 2024공시 • Mar 29FingerTango Inc., Annual General Meeting, Jun 21, 2024FingerTango Inc., Annual General Meeting, Jun 21, 2024.공시 • Mar 19FingerTango Inc. to Report Fiscal Year 2023 Results on Mar 28, 2024FingerTango Inc. announced that they will report fiscal year 2023 results on Mar 28, 2024공시 • Aug 30FingerTango Inc. Announces Change of Independent Non-Executive Directors and Change in Composition of Board CommitteesThe board of directors of FingerTango Inc. announced that Dr. Liu Jianhua ("Dr. Liu") has tendered his resignation as an independent non-executive Director and the chairman of the audit committee of the Company (the "Audit Committee") with effect from 29 August 2023 due to his other businessengagement; and Mr. Guo Jingdou ("Mr. Guo") has tendered his resignation as an independentnon-executive Director and the chairman of the remuneration committee (the"Remuneration Committee"), a member of each of the Audit Committee andnomination committee of the Company (the "Nomination Committee") with effectfrom 29 August 2023 due to his other business engagement. The Board announce that Mr. Chow Wing Yiu ("Mr. Chow") has been appointed as an independentnon-executive Director and the chairman of the Audit Committee with effect from 29August 2023; and Mr. Shin Ho Chuen ("Mr. Shin") has been appointed as an independent non-executiveDirector and a member of each of the Audit Committee, the Remuneration Committeeand the Nomination Committee with effect from 29 August 2023.공시 • Aug 22FingerTango Inc. to Report First Half, 2023 Results on Aug 31, 2023FingerTango Inc. announced that they will report first half, 2023 results on Aug 31, 2023공시 • Jul 23+ 1 more updateFingerTango Inc. Announces Appointment of Ho Kim Fung as Chief Financial OfficerThe board of directors of FingerTango Inc. announced that Mr. Ho Kim Fung ("Mr. Ho") has been appointed as chief financial officer of the Company with effect from 21 July 2023. Mr. Ho, aged 35, has over 9 years of working experience in accounting, auditing, and financial management. For his working experience, Mr. Ho had served as an auditor in several professional firms of Certified Public Accountants in Hong Kong. Since 2017, Mr. Ho provides accounting and financial management services in several listed companies in Hong Kong. Between 2018 to 2019, Mr. Ho was appointed as an independent non-executive director and concurrently as the chairman of audit committee and risk management committee of a listed company in Hong Kong. Mr. Ho is currently the company secretary of a company listed on the main board of the Stock Exchange since 16 May 2019. Mr. Ho holds a degree of Bachelor of Business Administration in Accounting from Hong Kong Metropolitan University. For the aspect of professional qualifications, Mr. Ho is a member of Hong Kong Institute of Certified Public Accountants, a member of the Association of Chartered Certified Accountants, a member of CPA Australia, an associate member of Chartered Institute of Management Accountants and a designation holder of The Chartered Global Management Accountant.공시 • Jun 30FingerTango Inc. Announces Management ChangesThe board of directors of FingerTango Inc. announced that, Dr. Chan Man Fung ("Dr. Chan") has been appointed as an executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee") with effect from 29 June 2023. Dr. Chan, aged 36, received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan also is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for types 1 (dealing in securities), 2 (dealing in future contracts), 4 (advising on securities) and 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and currently is the substantial shareholder of a corporation licensed by the Securities and Futures Commission (the "SFC") to carry out types 1 (dealing in securities), 4 (advising on securities) and 9 (asset management) regulated activities under the SFO. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China (the "PRC"). Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the PRC and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that, Mr. Sui Pengda ("Mr. Sui") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee of the Company (the "Audit Committee"), Remuneration Committee and nomination committee of the Company (the "Nomination Committee") with effect from 29 June 2023 due to his other business engagement. The Board announced that Mr. Jiang Huihui ("Mr. Jiang") has been appointed as an independent non-executive Director and a member of each of the Audit Committee, Remuneration Committee and Nomination Committee with effect from 29 June 2023. Mr. Jiang, aged 39, obtained a bachelor degree of Engineering from University of Central Lancashire in 2005 and a degree of Master of Engineering Studies from University of Technology, Sydney in 2007. Mr. Jiang has extensive experience in finance, investment fund management and the media and entertainment related businesses. Mr. Jiang is currently the general manager of an assets management company located in Beijing, the PRC, responsible for the management of overall operation of the company. Mr. Jiang is also the management consultant of a film and television production company located in Beijing, the PRC, responsible for identifying issues in the company and developing plans of action for enhancing performance. Following the above mentioned resignation and appointment, the composition of the Board committees has changed with effect from 29 June 2023 as follows: Dr. Chan has been appointed as a member of the Remuneration Committee; Mr. Sui has ceased to be a member of each of the Audit Committee, Remuneration Committee and Nomination Committee; and Mr. Jiang has been appointed as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee. The Board announced that Mr. Liu Jie ("Mr. Liu") has ceased to be an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Listing Rules with effect from 29 June 2023. The Board announced that Dr. Chan Man Fung has been appointed as the Authorised Representative in replacement of Mr. Liu with effect from 29 June 2023.공시 • Jun 24FingerTango Inc. Announces Resignation of Zhu Yanbin as an Executive Director and A Member of Remuneration CommitteeThe board of directors of FingerTango Inc. announced that Mr. Zhu Yanbin (Mr. Zhu) has tendered his resignation as an executive director and a member of remuneration committee of the company with effect from 23 June 2023 due to his other business engagement.주주 수익률FGRT.FUS EntertainmentUS 시장7D0%2.5%1.0%1Y-77.6%-10.4%28.7%전체 주주 수익률 보기수익률 대 산업: FGRT.F은 지난 1년 동안 -10.4%의 수익을 기록한 US Entertainment 산업보다 저조한 성과를 냈습니다.수익률 대 시장: FGRT.F은 지난 1년 동안 28.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is FGRT.F's price volatile compared to industry and market?FGRT.F volatilityFGRT.F Average Weekly Movementn/aEntertainment Industry Average Movement9.0%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%안정적인 주가: FGRT.F는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: Insufficient data to determine FGRT.F의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2013347Jie Liuwww.fingertango.com더 보기FingerTango Inc. 기초 지표 요약FingerTango의 순이익과 매출은 시가총액과 어떻게 비교됩니까?FGRT.F 기초 통계시가총액US$19.68m순이익 (TTM)-US$13.55m매출 (TTM)US$105.40m0.2x주가매출비율(P/S)-1.4x주가수익비율(P/E)FGRT.F는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표FGRT.F 손익계산서 (TTM)매출CN¥752.34m매출원가CN¥293.39m총이익CN¥458.95m기타 비용CN¥555.65m순이익-CN¥96.71m최근 보고된 실적Jun 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)-0.05총이익률61.00%순이익률-12.85%부채/자본 비율0%FGRT.F의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/12/19 17:11종가2023/09/21 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FingerTango Inc.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.
공시 • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026
공시 • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025
공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.
공시 • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025
공시 • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.
공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 05, 2026FingerTango Inc., Annual General Meeting, Jun 05, 2026.
공시 • Mar 11FingerTango Inc. to Report Fiscal Year 2025 Results on Mar 30, 2026FingerTango Inc. announced that they will report fiscal year 2025 results on Mar 30, 2026
공시 • Aug 15FingerTango Inc. to Report First Half, 2025 Results on Aug 28, 2025FingerTango Inc. announced that they will report first half, 2025 results on Aug 28, 2025
공시 • Mar 31FingerTango Inc., Annual General Meeting, Jun 12, 2025FingerTango Inc., Annual General Meeting, Jun 12, 2025.
공시 • Mar 14FingerTango Inc. to Report Fiscal Year 2024 Results on Mar 28, 2025FingerTango Inc. announced that they will report fiscal year 2024 results on Mar 28, 2025
공시 • Jan 10+ 1 more updateFingerTango Inc. Appoints Chan Man Fung as the Chairman of the BoardThe board of directors of FingerTango Inc. announced that Dr. CHAN Man Fung, executive Director of the Company, has been appointed as the chairman of the Board of the Company with effect from 10 January 2025. Dr. Chan, aged 38, has been appointed as an executive Director and a member of the remuneration committee of the Company with effect from 29 June 2023. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China. Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the People's Republic of China and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of the board of directors of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited. Dr. Chan received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for type 1 (dealing in securities), type 2 (dealing in future contracts), type 4 (advising on securities) and type 9 (asset management) regulated activities under the Securities and Futures Ordinance (chapter 571 of the laws of Hong Kong) and currently is the ultimate beneficial owner of two companies licensed by the Securities and Futures Commission to carry out type 1 (dealing in securities) regulated activities under the SFO, and type 4 (advising on securities) and type 9 (asset management) regulated activities under the SFO respectively.
공시 • Dec 19+ 1 more updateFingertango Inc. Announces Resignation of Liu Jie as CEOThe board of directors of FingerTango Inc. announced that Mr. Liu Jie has tendered his resignation as chief executive officer of the Company, all with effect from 16 December 2024, due to his other business commitments.
공시 • Dec 05FingeTtango Inc. Appoints Li Nini as an Executive DirectorThe board (the "Board") of directors (the "Directors" each a "Director") of FingerTango Inc. announce that, Ms. Li Nini ("Ms. Li") has been appointed as an executive Director of the Company with effect from 5 December 2024. The biographical details of Ms. Li are set out below: Ms. Li Nin, aged 42, join the Group on 3 December 2013. Ms. Li is vice president of the Group, mainly responsible for the business operation and project management. She has served as vice president of Shanghai Youmin Networks Technology Limited, a subsidiary of the Company, since December 2013. She is also the director of certain subsidiaries of the Group. Prior to joining the Group, she has worked with the founders of the Group. Ms. Li has over 10 years of experience in online game operation and management. Ms. Li graduated from Guangdong Ocean University with a bachelor degree in food science and engineering in June 2006 and graduated from Guangdong University of Technology with a master degree in food science in June 2009.
공시 • Aug 16FingerTango Inc. to Report First Half, 2024 Results on Aug 28, 2024FingerTango Inc. announced that they will report first half, 2024 results on Aug 28, 2024
공시 • Mar 29FingerTango Inc., Annual General Meeting, Jun 21, 2024FingerTango Inc., Annual General Meeting, Jun 21, 2024.
공시 • Mar 19FingerTango Inc. to Report Fiscal Year 2023 Results on Mar 28, 2024FingerTango Inc. announced that they will report fiscal year 2023 results on Mar 28, 2024
공시 • Aug 30FingerTango Inc. Announces Change of Independent Non-Executive Directors and Change in Composition of Board CommitteesThe board of directors of FingerTango Inc. announced that Dr. Liu Jianhua ("Dr. Liu") has tendered his resignation as an independent non-executive Director and the chairman of the audit committee of the Company (the "Audit Committee") with effect from 29 August 2023 due to his other businessengagement; and Mr. Guo Jingdou ("Mr. Guo") has tendered his resignation as an independentnon-executive Director and the chairman of the remuneration committee (the"Remuneration Committee"), a member of each of the Audit Committee andnomination committee of the Company (the "Nomination Committee") with effectfrom 29 August 2023 due to his other business engagement. The Board announce that Mr. Chow Wing Yiu ("Mr. Chow") has been appointed as an independentnon-executive Director and the chairman of the Audit Committee with effect from 29August 2023; and Mr. Shin Ho Chuen ("Mr. Shin") has been appointed as an independent non-executiveDirector and a member of each of the Audit Committee, the Remuneration Committeeand the Nomination Committee with effect from 29 August 2023.
공시 • Aug 22FingerTango Inc. to Report First Half, 2023 Results on Aug 31, 2023FingerTango Inc. announced that they will report first half, 2023 results on Aug 31, 2023
공시 • Jul 23+ 1 more updateFingerTango Inc. Announces Appointment of Ho Kim Fung as Chief Financial OfficerThe board of directors of FingerTango Inc. announced that Mr. Ho Kim Fung ("Mr. Ho") has been appointed as chief financial officer of the Company with effect from 21 July 2023. Mr. Ho, aged 35, has over 9 years of working experience in accounting, auditing, and financial management. For his working experience, Mr. Ho had served as an auditor in several professional firms of Certified Public Accountants in Hong Kong. Since 2017, Mr. Ho provides accounting and financial management services in several listed companies in Hong Kong. Between 2018 to 2019, Mr. Ho was appointed as an independent non-executive director and concurrently as the chairman of audit committee and risk management committee of a listed company in Hong Kong. Mr. Ho is currently the company secretary of a company listed on the main board of the Stock Exchange since 16 May 2019. Mr. Ho holds a degree of Bachelor of Business Administration in Accounting from Hong Kong Metropolitan University. For the aspect of professional qualifications, Mr. Ho is a member of Hong Kong Institute of Certified Public Accountants, a member of the Association of Chartered Certified Accountants, a member of CPA Australia, an associate member of Chartered Institute of Management Accountants and a designation holder of The Chartered Global Management Accountant.
공시 • Jun 30FingerTango Inc. Announces Management ChangesThe board of directors of FingerTango Inc. announced that, Dr. Chan Man Fung ("Dr. Chan") has been appointed as an executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee") with effect from 29 June 2023. Dr. Chan, aged 36, received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006. Dr. Chan also is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for types 1 (dealing in securities), 2 (dealing in future contracts), 4 (advising on securities) and 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and currently is the substantial shareholder of a corporation licensed by the Securities and Futures Commission (the "SFC") to carry out types 1 (dealing in securities), 4 (advising on securities) and 9 (asset management) regulated activities under the SFO. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China (the "PRC"). Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the PRC and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that, Mr. Sui Pengda ("Mr. Sui") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee of the Company (the "Audit Committee"), Remuneration Committee and nomination committee of the Company (the "Nomination Committee") with effect from 29 June 2023 due to his other business engagement. The Board announced that Mr. Jiang Huihui ("Mr. Jiang") has been appointed as an independent non-executive Director and a member of each of the Audit Committee, Remuneration Committee and Nomination Committee with effect from 29 June 2023. Mr. Jiang, aged 39, obtained a bachelor degree of Engineering from University of Central Lancashire in 2005 and a degree of Master of Engineering Studies from University of Technology, Sydney in 2007. Mr. Jiang has extensive experience in finance, investment fund management and the media and entertainment related businesses. Mr. Jiang is currently the general manager of an assets management company located in Beijing, the PRC, responsible for the management of overall operation of the company. Mr. Jiang is also the management consultant of a film and television production company located in Beijing, the PRC, responsible for identifying issues in the company and developing plans of action for enhancing performance. Following the above mentioned resignation and appointment, the composition of the Board committees has changed with effect from 29 June 2023 as follows: Dr. Chan has been appointed as a member of the Remuneration Committee; Mr. Sui has ceased to be a member of each of the Audit Committee, Remuneration Committee and Nomination Committee; and Mr. Jiang has been appointed as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee. The Board announced that Mr. Liu Jie ("Mr. Liu") has ceased to be an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Listing Rules with effect from 29 June 2023. The Board announced that Dr. Chan Man Fung has been appointed as the Authorised Representative in replacement of Mr. Liu with effect from 29 June 2023.
공시 • Jun 24FingerTango Inc. Announces Resignation of Zhu Yanbin as an Executive Director and A Member of Remuneration CommitteeThe board of directors of FingerTango Inc. announced that Mr. Zhu Yanbin (Mr. Zhu) has tendered his resignation as an executive director and a member of remuneration committee of the company with effect from 23 June 2023 due to his other business engagement.
